Marlowe (LON:MRL - Get Free Report) announced its quarterly earnings results on Thursday. The company reported GBX 15.30 ($0.21) earnings per share (EPS) for the quarter, Digital Look Earnings reports. Marlowe had a negative return on equity of 2.33% and a negative net margin of 2.03%.
Marlowe Price Performance
Shares of MRL stock opened at GBX 441.22 ($6.03) on Thursday. The company has a debt-to-equity ratio of 58.99, a quick ratio of 0.80 and a current ratio of 1.24. Marlowe has a fifty-two week low of GBX 220 ($3.01) and a fifty-two week high of GBX 490 ($6.69). The firm has a market cap of £353.07 million, a P/E ratio of -41.04 and a beta of 0.44. The business's 50 day moving average price is GBX 380.19 and its 200-day moving average price is GBX 343.97.
About Marlowe
(
Get Free Report)
Marlowe is a leader in business-critical services and software which assure regulatory compliance. The company was formed to create sustainable shareholder value through the acquisition and development of businesses that provide regulated safety and compliance services and software. It is focused on compliance software, eLearning, health & safety, employment law & HR compliance, fire safety & security, water & air hygiene and occupational health services - all of which are vital to the wellbeing of its customers operations and are invariably governed by regulation.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Marlowe, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Marlowe wasn't on the list.
While Marlowe currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
